Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 053614/0218 | |
| Pages: | 5 |
| | Recorded: | 08/27/2020 | | |
| Attorney Dkt #: | Q257411 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16976140
|
Filing Dt:
|
08/27/2020
|
|
Publication #:
|
|
Pub Dt:
|
12/31/2020
| | | | |
|
Title:
|
PHARMACEUTICAL COMPOSITION CONTAINING (R)-N-[1-(3,5-DIFLUORO-4-METHANESULFONYLAMINO-PHENYL)-ETHYL]-3-(2-PROPYL-6-TRIFLUOROMETHYLPYRIDIN-3-YL)-ACRYLAMIDE AND METHOD FOR INHIBITING CRYSTAL FORMATION THEREOF
|
|
|
Assignee
|
|
|
|
|
| (HANGANG-RO-2GA) 100, HANGANG-DAERO, YONGSAN-GU |
| SEOUL, KOREA, REPUBLIC OF 04386 |
|
|
Correspondence name and address
|
| |
SUGHRUE MION, PLLC
|
| |
2000 PENNSYLVANIA AVENUE, N.W.
|
| |
SUITE 900
|
| |
WASHINGTON, DC 20006
|
Search Results as of:
05/14/2024 04:48 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
